Factors limiting the efficiency of immunomagnetic cell separation.
Mansour
V
V
Fenwal Biomedical Therapy Systems, Baxter Healthcare Corporation, Santa Ana, California.
Weiler
M
M
Gee
A
A
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D001665:Binding Sites; D016465:Bone Marrow Purging / Q000379:methods*; D002469:Cell Separation / Q000379:methods; D005069:Evaluation Studies as Topic; D005434:Flow Cytometry; D006801:Humans; D008280:Magnetics; D014407:Tumor Cells, Cultured / Q000166:cytology / Q000276:immunology
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm